Section : Research
John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.
Section : Research
As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.
Section : Research
Suzanne King is investigating risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.
Section : Research
Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.
Section : Research
Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.
Section : Research
Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.
Section : Research
Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.
Section : Research
Thomas Brown studies the development of psychosocial interventions to combat substance abuse.
Section : Research
Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.
Section : Social Media
Opening - Parle-moi d'amour at the Wellington Centre from February 6 to March 13, 2014